Publication | Open Access
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
1.3K
Citations
12
References
2009
Year
Mepolizumab reduced the number of blood and sputum eosinophils and allowed prednisone sparing in patients who had asthma with sputum eosinophilia despite prednisone treatment. (ClinicalTrials.gov number, NCT00292877.)
| Year | Citations | |
|---|---|---|
Page 1
Page 1